HS Code:
The 'For veterinary use' category, primarily classified under HS Code 3002.30 (vaccines for veterinary medicine) and related subcategories, encompasses pharmaceutical products, vaccines, and medical preparations specifically designed for animal health. This includes treatments for livestock, pets, and other animals, addressing diseases, infections, and overall welfare. The global trade of veterinary products is driven by the increasing demand for animal health products due to rising pet ownership, growth in livestock production to meet food demands, and heightened awareness of zoonotic diseases.
Total Trade Volume
USD 12.5 billion
Data from 2022
Source
United Nations Comtrade Database & World Trade Organization (WTO)
USD 3.2 billion
25.6% of total trade of total trade
Increasing
USD 1.8 billion
14.4% of total trade of total trade
Stable
USD 1.5 billion
12.0% of total trade of total trade
Increasing
USD 1.1 billion
8.8% of total trade of total trade
Increasing
USD 0.9 billion
7.2% of total trade of total trade
Increasing
Average Rate
5.2% ad valorem
Highest Rate
15% (imposed by certain developing countries to protect domestic industries)
Lowest Rate
0% (under free trade agreements like EU-US TTIP or within WTO member states with specific exemptions)
Rising demand for pet healthcare products
Increased trade in veterinary pharmaceuticals for companion animals due to growing pet ownership and humanization of pets, particularly in developed markets like North America and Europe.
2021-2022
Growth in livestock production
Higher exports of veterinary vaccines and antibiotics to support intensive farming in regions like Asia-Pacific and Latin America to meet global meat and dairy demand.
2020-2022
Focus on zoonotic disease prevention
Boost in trade for veterinary diagnostics and preventive medicines as governments and organizations prioritize animal health to prevent outbreaks like avian flu or swine fever.
2021-2023
The European Union implemented stricter regulations under Regulation (EU) 2019/6, mandating enhanced traceability and safety standards for veterinary medicinal products.
January 28, 2022
Increased compliance costs for exporters to the EU, potentially affecting smaller suppliers, while ensuring higher safety standards for animal health products.
As part of the Phase One trade deal, China agreed to reduce certain non-tariff barriers on US veterinary products, facilitating smoother market access.
February 2020 (reaffirmed in 2022)
Boosted US exports of veterinary vaccines and treatments to China, supporting American manufacturers and addressing China's growing livestock needs.
International bodies like the World Organisation for Animal Health (OIE) have pushed for reduced use of antibiotics in veterinary medicine to combat antimicrobial resistance (AMR).
Ongoing, highlighted in 2023
Shift in trade patterns towards alternative treatments and vaccines, with reduced demand for traditional antibiotics in key markets like the EU and North America.